Search results
Jefferson Hills neighbors weigh in on controversial cell tower proposal ahead of council vote
WPXI· 1 day agoThe Jefferson Hills Borough Council meeting was packed with neighbors who were both for and against...
Don’t ‘Cell Out’ San Mateo
San Mateo Daily Journal· 19 hours agoYou may have recently noticed special antennas being attached to light poles across the city of San Mateo. The people of San Mateo are pushing back...
Blockbuster cancer drug Calquence hits primary endpoint in trial for first-line mantle cell lymphoma
Endpoints News· 11 hours agoAstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell...
Earnings call: Cerus Corporation sees growth with INTERCEPT RBCs trial success
Investing.com· 4 hours agoCerus Corporation (NASDAQ: CERS ) has announced positive outcomes from its Phase 3 ReCePI clinical...
Astellas and Poseida join forces for cancer cell therapy By Investing.com
Investing.com· 1 day agoAstellas Pharma Inc. (TSE: 4503) and Poseida Therapeutics, Inc. (NASDAQ: PSTX) have entered a...
Ozzy Osbourne Opens Up About His Stem Cell Treatment for Parkinson’s Disease
Consequence of Sound via Yahoo News· 2 days agoOzzy offered an update on his health on his SiriusXM program with Billy Morrison. Ozzy Osbourne...
Jefferson Hills neighbors weigh in on controversial cell tower proposal ahead of council vote
WPXI via Yahoo News· 1 day agoThe Jefferson Hills Borough Council meeting was packed with neighbors who were both for and against a controversial proposal to build a cell phone tower near a football field.
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 2 days agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
...Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel...
The West Side Index & Gustine Press-Standard· 1 day agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
BioPharma Dive via Yahoo Finance· 2 days agoAstellas Pharma is betting again on cell therapy, announcing Wednesday a deal with Poseida...